Inception Return
(7/31/1995)
|
6.77 %
|
|
YTD Return
|
-20.64 %
|
|
NAVPS
(6/24/2022)
|
$29.56
|
|
Change
|
$0.74 / 2.56 %
|
|
|
Growth of $10,000
(As of May 31, 2022)
|
|
MER
|
2.05 %
|
|
Assets ($mil)
|
$465.17
|
|
Rank (1Yr)
|
994/1526
|
|
Std Dev (3Yr)
|
14.98 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The objective of the fund is to provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.
|
Fund Manager
RBC Global Asset Management Inc.
Portfolio Manager
Rob Cavallo, RBC Global Asset Management Inc.
Marcello Montanari, RBC Global Asset Management Inc.
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of February 28, 2022)
|
Sector Allocation
(As of February 28, 2022)
|
Geographic Allocation
(As of February 28, 2022)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Microsoft Corp | US Equity | Technology | United States | 10.20% |
| Apple Inc | US Equity | Technology | United States | 9.27% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 9.15% |
| NVIDIA Corp | US Equity | Technology | United States | 3.60% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 3.18% |
| Meta Platforms Inc Cl A | US Equity | Technology | United States | 2.64% |
| Cash & Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.53% |
| Visa Inc Cl A | US Equity | Financial Services | United States | 2.28% |
| Mastercard Inc Cl A | US Equity | Financial Services | United States | 2.13% |
| Johnson & Johnson | US Equity | Healthcare | United States | 1.76% |
Performance Data
(As of May 31, 2022)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-2.60
|
-9.67
|
-18.27
|
-20.64
|
-2.83
|
13.95
|
12.84
|
17.24
|
|
Benchmark
|
-0.94
|
-5.53
|
-9.87
|
-12.96
|
4.46
|
13.86
|
11.92
|
16.74
|
|
Quartile Ranking
|
4
|
4
|
4
|
4
|
3
|
1
|
1
|
1
|
|
Calendar Return (%)
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
|
Fund
|
24.97
|
29.23
|
25.94
|
8.77
|
22.08
|
-0.84
|
21.81
|
26.86
|
49.09
|
7.22
|
|
Benchmark
|
28.16
|
16.07
|
25.18
|
3.98
|
13.80
|
8.65
|
20.77
|
24.19
|
41.93
|
13.16
|
|
Quartile Ranking
|
2
|
1
|
2
|
1
|
1
|
4
|
1
|
1
|
1
|
4
|